Hostname: page-component-848d4c4894-cjp7w Total loading time: 0 Render date: 2024-06-26T23:35:08.850Z Has data issue: false hasContentIssue false
  • English
  • Français

Endocannabinoids in schizophrenia and other psychiatric disorders

Published online by Cambridge University Press:  16 April 2020

F.M. Leweke ,
A. Giuffrida ,
C.W. Gerth ,
J. Faulhaber ,
K. Klosterkötter  and
D. Piomelli
F.M. Leweke
Affiliation:
University of Cologne, Department of Psychiatry & Psychotherapy, Germany
A. Giuffrida
Affiliation:
University of California, Irvine, USA
C.W. Gerth
Affiliation:
University of Cologne, Department of Psychiatry & Psychotherapy, Germany
J. Faulhaber
Affiliation:
University of Cologne, Department of Psychiatry & Psychotherapy, Germany
K. Klosterkötter
Affiliation:
University of Cologne, Department of Psychiatry & Psychotherapy, Germany
D. Piomelli
Affiliation:
University of California, Irvine, USA

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Posters, Monday, 6 May 2002
Information
European Psychiatry , Volume 17 , Issue S1 , May 2002 , pp. 156s
Copyright
Copyright © Elsevier, Paris 2002
Submit a response

Comments

No Comments have been published for this article.